Name: Parkinson's Disease: Understanding Pathophysiology and Developing Therapeutic Strategies (en Inglés)
SKU: 56681137
Price: 156300.00 CLP
Availability: InStock
Author: Yenisetti, Sarat Chandra
ISBN: 9781789231526

portada Parkinson's Disease: Understanding Pathophysiology and Developing Therapeutic Strategies (en Inglés)

Parkinson's Disease: Understanding Pathophysiology and Developing Therapeutic Strategies (en Inglés)

Formato

Libro Físico

Editorial

Intechopen

Autor

Yenisetti, Sarat Chandra

Idioma

Inglés

N° páginas

128

Encuadernación

Tapa Dura

Dimensiones

24.4x17x1 cm

Peso

0.41 kg.

ISBN13

9781789231526

Categorías

Neurología y neurofisiología clínicas

Parkinson's Disease: Understanding Pathophysiology and Developing Therapeutic Strategies (en Inglés)

Yenisetti, Sarat Chandra (Autor) · Intechopen · Tapa Dura

Libro Nuevo Importado

Envío: 20 a 24 días háb.

$ 284.190$ 156.300

-45%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan 10 unidades

$ 156.300

Llega entre el 14 Oct y el 20 Oct a Santiago, Región Metropolitana. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Parkinson's Disease: Understanding Pathophysiology and Developing Therapeutic Strategies (en Inglés)"

Parkinson's disease (PD) is the second most common neurodegenerative disorder results due to loss of dopamine producing brain cells. Knowledge relating to PD condition has been known since 5000BC, however no effective therapeutic strategies are available till today. Therefore it is important for neurobiologists to work further by taking advantage of modern scientific methods and develop appropriate therapeutic strategies. Efforts in this direction are worthy as they will reduce the burden of PD among elderly, who are already burdened with age related systemic degenerative processes. This book is a humble effort in that progressive direction. It has chapters covering multiple aspects relating to etiology, pathophysiology of PD, available and futuristic therapeutics strategies. Therefore it will be of interest to common man, biomedical researchers and clinicians. This is one small step in a direction "to reduce the burden of neurological disease."